Logo image of LXG.CA

LEXAGENE HOLDINGS INC (LXG.CA) Stock Fundamental Analysis

TSX-V:LXG - TSX Venture Exchange - CA52886L1031 - Common Stock - Currency: CAD

0.105  -0.03 (-19.23%)

Fundamental Rating

1

Taking everything into account, LXG scores 1 out of 10 in our fundamental rating. LXG was compared to 15 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of LXG have multiple concerns. LXG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LXG has reported negative net income.
LXG had a negative operating cash flow in the past year.
LXG had negative earnings in each of the past 5 years.
LXG had a negative operating cash flow in each of the past 5 years.
LXG.CA Yearly Net Income VS EBIT VS OCF VS FCFLXG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M -8M -10M

1.2 Ratios

The profitability ratios for LXG are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LXG.CA Yearly ROA, ROE, ROICLXG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 200 -200 -400 -600

1.3 Margins

LXG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LXG.CA Yearly Profit, Operating, Gross MarginsLXG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 -5K -10K -15K

More info and screens

1

2. Health

2.1 Basic Checks

LXG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LXG has more shares outstanding
The debt/assets ratio for LXG is higher compared to a year ago.
LXG.CA Yearly Shares OutstandingLXG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
LXG.CA Yearly Total Debt VS Total AssetsLXG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

LXG has an Altman-Z score of -32.50. This is a bad value and indicates that LXG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -32.50, LXG is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
LXG has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
LXG has a Debt to Equity ratio of 0.44. This is in the lower half of the industry: LXG underperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z -32.5
ROIC/WACCN/A
WACC9.69%
LXG.CA Yearly LT Debt VS Equity VS FCFLXG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 1.39 indicates that LXG should not have too much problems paying its short term obligations.
LXG's Current ratio of 1.39 is on the low side compared to the rest of the industry. LXG is outperformed by 60.00% of its industry peers.
LXG has a Quick Ratio of 1.39. This is a bad value and indicates that LXG is not financially healthy enough and could expect problems in meeting its short term obligations.
LXG has a worse Quick ratio (0.51) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.51
LXG.CA Yearly Current Assets VS Current LiabilitesLXG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for LXG have decreased strongly by -45.78% in the last year.
The Revenue has grown by 32.22% in the past year. This is a very strong growth!
EPS 1Y (TTM)-45.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.52%
Revenue 1Y (TTM)32.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LXG.CA Yearly Revenue VS EstimatesLXG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 500K 1M 1.5M 2M 2.5M
LXG.CA Yearly EPS VS EstimatesLXG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 -0.05 -0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LXG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LXG.CA Price Earnings VS Forward Price EarningsLXG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LXG.CA Per share dataLXG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LXG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LEXAGENE HOLDINGS INC

TSX-V:LXG (2/21/2023, 7:00:00 PM)

0.105

-0.03 (-19.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.77M
Analysts84.44
Price Target0.51 (385.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 55.84
P/FCF N/A
P/OCF N/A
P/B 8.53
P/tB 8.76
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.51
Altman-Z -32.5
F-Score3
WACC9.69%
ROIC/WACCN/A
Cap/Depr(3y)9.71%
Cap/Depr(5y)721.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.81%
OCF growth 3YN/A
OCF growth 5YN/A